{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:28:27Z","timestamp":1790522907393,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.brainres.2019.01.029","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T02:15:33Z","timestamp":1548382533000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Deletion of the vesicular monoamine transporter 1 (vmat1\/slc18a1) gene affects dopamine signaling"],"prefix":"10.1016","volume":"1712","author":[{"given":"Falk W.","family":"Lohoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory V.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Brookshire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Lucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2019.01.029_b0005","first-page":"253","article-title":"Vesicular monoamine transporter-1 (VMAT-1) mRNA and immunoreactive proteins in mouse brain","volume":"32","author":"Ashe","year":"2011","journal-title":"Neuro. Endocrinol. Lett."},{"key":"10.1016\/j.brainres.2019.01.029_b0010","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/npp.2008.234","article-title":"Enhanced sensitivity of the MRL\/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments","volume":"34","author":"Balu","year":"2009","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.brainres.2019.01.029_b0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2012.11.027","article-title":"Brain monoamines and antidepressant-like responses in MRL\/MpJ versus C57BL\/6J mice","volume":"67","author":"Balu","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.01.029_b0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.schres.2005.04.011","article-title":"Mutation in the vesicular monoamine gene, SLC18A1, associated with schizophrenia","volume":"78","author":"Bly","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainres.2019.01.029_b0025","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","article-title":"Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration","volume":"27","author":"Caudle","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.01.029_b0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.schres.2006.11.022","article-title":"Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia","volume":"90","author":"Chen","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainres.2019.01.029_b0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2174\/156802611795371332","article-title":"Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse","volume":"11","author":"Crooks","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.brainres.2019.01.029_b0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-005-0166-5","article-title":"Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test","volume":"183","author":"Crowley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.01.029_b0045","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/acer.12991","article-title":"Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1\/SLC18A1) Gene and Alcohol Withdrawal Severity","volume":"40","author":"Dutta","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.brainres.2019.01.029_b0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2010.05906.x","article-title":"VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse","volume":"1216","author":"Eiden","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2019.01.029_b0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/syn.20896","article-title":"Ephedrine decreases vesicular monoamine transporter-2 function","volume":"65","author":"Ellis","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2019.01.029_b0060","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1073\/pnas.89.22.10993","article-title":"Expression cloning of a reserpine-sensitive vesicular monoamine transporter","volume":"89","author":"Erickson","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2019.01.029_b0065","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.93.10.5166","article-title":"Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter","volume":"93","author":"Erickson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2019.01.029_b0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2019.01.029_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuropharm.2008.07.002","article-title":"Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications","volume":"56","author":"Fleckenstein","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.01.029_b0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0896-6273(00)80418-3","article-title":"Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action","volume":"19","author":"Fon","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.01.029_b0085","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.brainres.2019.01.029_b0090","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1523\/JNEUROSCI.19-07-02424.1999","article-title":"Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice","volume":"19","author":"Fumagalli","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.01.029_b0095","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.npp.1300070","article-title":"Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice","volume":"28","author":"Hall","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.01.029_b0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-3806(98)00104-7","article-title":"Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system","volume":"110","author":"Hansson","year":"1998","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.brainres.2019.01.029_b0105","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1523\/JNEUROSCI.5996-09.2010","article-title":"Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum","volume":"30","author":"Ibanez-Sandoval","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.01.029_b0110","first-page":"1111","article-title":"Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT1A and 5-HT1B receptors","volume":"292","author":"Knobelman","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2019.01.029_b0115","first-page":"1268","article-title":"Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei","volume":"269","author":"Kreiss","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2019.01.029_b0120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(92)90425-C","article-title":"A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter","volume":"70","author":"Liu","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2019.01.029_b0125","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/sj.npp.1301196","article-title":"Variations in the vesicular monoamine transporter 1 gene (VMAT1\/SLC18A1) are associated with bipolar i disorder","volume":"31","author":"Lohoff","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.01.029_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neulet.2008.01.024","article-title":"Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits","volume":"434","author":"Lohoff","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2019.01.029_b0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000129668","article-title":"Association between polymorphisms in the vesicular monoamine transporter 1 gene (VMAT1\/SLC18A1) on chromosome 8p and schizophrenia","volume":"57","author":"Lohoff","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.brainres.2019.01.029_b0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/mp.2012.193","article-title":"Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing","volume":"19","author":"Lohoff","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.01.029_b0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002130100687","article-title":"Limitations on the use of the C57BL\/6 mouse in the tail suspension test","volume":"155","author":"Mayorga","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.01.029_b0150","article-title":"Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure","author":"McFadden","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2019.01.029_b0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroscience.2012.11.023","article-title":"VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination","volume":"232","author":"Multani","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2019.01.029_b0160","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/npp.2011.142","article-title":"Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences","volume":"36","author":"Narboux-Neme","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.01.029_b0165","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ejhg.2008.264","article-title":"Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis","volume":"17","author":"Need","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.brainres.2019.01.029_b0170","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0888-7543(05)80383-0","article-title":"Chromosomal localization of the human vesicular amine transporter genes","volume":"18","author":"Peter","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.brainres.2019.01.029_b0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1744-9081-2-39","article-title":"Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population","volume":"2","author":"Richards","year":"2006","journal-title":"Behav Brain Funct."},{"key":"10.1016\/j.brainres.2019.01.029_b0180","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.euroneuro.2015.06.013","article-title":"Impaired adrenal medullary function in a mouse model of depression induced by unpredictable chronic stress","volume":"25","author":"Santana","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2019.01.029_b0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.alcohol.2006.09.030","article-title":"Altered ethanol-associated behaviors in vesicular monoamine transporter heterozygote knockout mice","volume":"40","author":"Savelieva","year":"2006","journal-title":"Alcohol."},{"key":"10.1016\/j.brainres.2019.01.029_b0190","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1073\/pnas.94.18.9938","article-title":"VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity","volume":"94","author":"Takahashi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2019.01.029_b0195","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/syn.20573","article-title":"Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration","volume":"62","author":"Tong","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2019.01.029_b0200","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1096\/fj.00-0205rev","article-title":"The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins","volume":"14","author":"Uhl","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2019.01.029_b0205","first-page":"19","article-title":"A functional vesicular monoamine transporter 1 (VMAT1) gene variant is associated with affect and the prevalence of anxiety, affective, and alcohol use disorders in a longitudinal population-representative birth cohort study","author":"Vaht","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2019.01.029_b0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2007.09.028","article-title":"Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels","volume":"1185","author":"Vergo","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.01.029_b0215","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/j.jchromb.2011.09.026","article-title":"Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometry","volume":"879","author":"Vieira-Brock","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.brainres.2019.01.029_b0220","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0896-6273(00)80419-5","article-title":"Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine","volume":"19","author":"Wang","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.01.029_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2017.02.028","article-title":"Vesicular monoamine transporter 1 gene polymorphism and white matter integrity in major depressive disorder","author":"Won","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.01.029_b0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuint.2007.06.022","article-title":"Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture","volume":"51","author":"Yamamoto","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2019.01.029_b0235","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1016\/j.bmc.2005.04.013","article-title":"Lobelane analogues as novel ligands for the vesicular monoamine transporter-2","volume":"13","author":"Zheng","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.brainres.2019.01.029_b0240","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1208\/aapsj080478","article-title":"Vesicular monoamine transporter 2: role as a novel target for drug development","volume":"8","author":"Zheng","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.brainres.2019.01.029_b0245","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1002\/hbm.22951","article-title":"Resting-state functional connectivity and presynaptic monoamine signaling in Alcohol Dependence","volume":"36","author":"Zhu","year":"2015","journal-title":"Hum. Brain Mapp."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319300459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319300459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:03:28Z","timestamp":1554768208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319300459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":49,"alternative-id":["S0006899319300459"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.01.029","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deletion of the vesicular monoamine transporter 1 (vmat1\/slc18a1) gene affects dopamine signaling","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}